7McCluggage WG.Recent advances in immunohistochemistry in gynaecological pathology.Histopathology,2002,40:309
8Vasquez MD,Ro TJ,Park YWet al.Angiomyofiblastoma:a clinopathologic study of eight cases and review of the literature.Int J Surg Pathol,1999,7:161
9Mori O,Hachisuka H,Nakano S et al.Expression of ras p21 in mammary and extramammary Paget's disease.Arch Pathol Med,1990,114:858
10Keatings L,Sinclair J,Wright C et al.c-cerB-2 oncoprotein expression in mammary and extramammary Paget's disease.An immunohistochemical study.Histopathology,1990,17:243
3Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum : Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm [ J ]. Am J Surg Pathol, 1983,7 (5) :463 - 475.
4Lopez Lopez C, Romero Maroto J, Quflez Fenoll JM, et al. New location of aggressive angiomyxoma: the bladder[ J]. Actas Urol Esp, 1993, 17(9) :611 -613.
5Cesarani F,Garretti L,Denegri F, et al. Sonographic appearance of aggressive angiomyxoma of the bladder[J]. J Clin Ultrasound, 1999, 27(7) :399 -401.
6May F, Luther A, Mohr W, et al. Recurrent aggressive angiomyxoma of the urinary bladder. Case report and review of the literature[J]. Urol Int, 2000, 65 ( 1 ) :57 - 59.
7Sawada Y, Ito F, Nakazawa H, et al. A rare benign genitourinary tumor in a Japanese male:urinary retention owing to aggressive angiomyxoma of the prostate[J]. Rare Tumors, 2010, 2(1): e15.
8Stewart MC, Kadlcek RM, Robbins PD, et al. Expression and activity of the CDK inhibitor p57 kip2 in chondrocytes under going hypertrophic differentiation[ J]. J Bone Miner Res, 2004, 19(1) :123 - 132.
9Bond GL,Hu W,Bond EE. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [ J ]. Cell, 2004, 119 (5) :591 - 602.
10Bigby SM, Symmans PJ, Miller MV, et al. Aggressive angiomyxoma of the female genital tract and pelvis - clinicopathologic features with immunohistochemical analysis [J]. Int J Gynecol Pathol, 2011, 30(5) :505 -513.
